FDA — authorised 21 October 1988
- Marketing authorisation holder: NOVARTIS
- Status: approved
🇺🇸 Sandostatin in United States
FDA authorised Sandostatin on 21 October 1988
Marketing authorisation
Sandostatin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Sandostatin approved in United States?
Yes. FDA authorised it on 21 October 1988.
Who is the marketing authorisation holder for Sandostatin in United States?
NOVARTIS holds the US marketing authorisation.